Home › Trials › NCT06398795
Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

New endoscopic surgery technique for thyroid tumors

Official title: Dual-port Trans-subclavian Thyroid Endoscopic Surgery - an Exploration of Cavity Construction in Situ Heralds a New Approach Choice

Run by First Affiliated Hospital of Wenzhou Medical University · NCT06398795 · Data updated 2026-11-12

This study is testing a new way to perform thyroid surgery using a small dual-port technique to see if it is safer and more effective than the traditional open surgery for people with thyroid tumors.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment300 (estimated)
SponsorFirst Affiliated Hospital of Wenzhou Medical University
Academic / other
Locations1 site (Wenzhou, Zhejiang)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 31, 2024
Trial IDNCT06398795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with thyroid cancer or benign thyroid tumors who desire cosmetic improvement from their incisions.

Probably not a fit

Patients with larger thyroid cancers or benign tumors, severe underlying diseases, or specific autoimmune conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center study evaluates a novel dual-port trans-subclavian approach to endoscopic thyroid surgery compared to traditional open thyroidectomy. It involves 300 patients with thyroid tumors, divided into an experimental group receiving the new technique and a control group undergoing conventional surgery. The study aims to assess the effectiveness and safety of the new method by comparing surgical complications and collecting laboratory data at specified follow-up points. Adverse events will also be meticulously recorded to provide comprehensive evidence-based insights.

Why it matters

Potential benefit: If successful, this approach could lead to reduced surgical complications and improved cosmetic outcomes for patients undergoing thyroid surgery.

How similar studies have gone: While endoscopic thyroid surgery has been explored, this specific dual-port approach is relatively novel and has not been widely tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Thyroid cancer or benign thyroid tumors
* Patients with a demand for incisional cosmetic improvement

Exclusion Criteria:

* Patients with thyroid cancer larger than 2 cm
* benign tumors larger than 5 cm
* Patients with severe underlying diseases
* Patients with chronic kidney disease,
* Patients with autoimmune diseases
* Patients with rheumatoid arthritis

Where it's running

  • First Affiliated Hospital of Wenzhou Medical University
    Wenzhou, Zhejiang, China     Recruiting

Study contacts

  • Principal investigator: Jiashu Wu, Profe — The first hospital of Wenzhou Medical University
  • Study coordinator: Chun Jin, Professor
  • Email: 845095442@qq.com
  • Phone: 86-13858707259

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Thyroid Neoplasms 11Endoscopic Surgery 3First Affiliated Hospital of Wenzhou Medical University 16
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.